Skip to content

A randomized, multicenter, open-label comparative study comparing a multimodal concept of systemic pain therapy with regional anesthesia in patients undergoing total knee replacement.

A randomized, multicenter, open-label comparative study comparing a multimodal concept of systemic pain therapy with regional anesthesia in patients undergoing total knee replacement.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014185
Enrollment
180
Registered
2018-03-01
Start date
2018-08-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

total knee replacement (OPS: 5-822) postoperative pain therapy using peripheral regional anaesthesia (OPS: 8-915) postoperative pain therapy using multimodal approach (OPS: 8-918)

Interventions

Group 1: In patients undergoing total knee replacement, analgesia is performed for 72 hours using multimodal systemic analgesia (MSA): Elements of the MSA are: - SSTS (sublingual sufentanil-based ther

Sponsors

Klinik für Anästhesie und Intensivtherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Unilateral knee endoprothesis Patients with (American Society of Anesthesiologists) ASA score 1 to 3 - Signed consent

Exclusion criteria

Exclusion criteria: - Patients with ASA score> 3 - Continued use of opioids (more than 6 weeks before the scheduled operation) - Clinically relevant obstructive sleep apnea syndrome - Clinically relevant COPD - pre-existing reduction in vigilance - respiratory depression, increased intracranial pressure - Contraindications to the use of Zalviso according to SPC of the system - severe coagulation disorders or other contraindications to the attachment of a peripheral nerve block - Allergies or intolerances to sufentanil - Allergies or hypersensitivity to local anesthetics of the amide type - Hepatic insufficiency with signs of a synthesis disorder - Cirrhosis Child-Pugh Grade B and C - pregnant or nursing patients - women of childbearing potential without contraception - Alcohol or drug abuse - Non-consenting patients - Participation in another study - Persons who are in a dependency or employment relationship with the sponsor or examiner - Imprisoned persons

Design outcomes

Primary

MeasureTime frame
Subjectively perceived quality of life in the perioperative period as measured by the PPP33 questionnaire (48 hours postoperatively)

Secondary

MeasureTime frame
Secondary objective criteria (confirmatory testing): - Subjective patient assessment of the postoperative period at 24h and 72h after surgery - Postoperative pain at rest and under stress (sum of all 8 NRS rating scales of the postoperative period) - Mobilizability (CAS test) - cumulative time spent by the patient outside the bed after surgery (patient diary) - Stability and gait safety (Tinetti test) - Ease of care questionnaire for nursing staff or physiotherapists - Patient assessment of the analgesia procedure or patient satisfaction (Harding questionnaire and question for recommending the Analgesieverfahrens to friends and relatives) - Assessment of the preoperative phase in the OP (ISAS questionnaire) Secondary objective criteria (descriptive analysis): - Quality of life (SF36) - Disease-specific quality of life (Oxford knee score) - Co-medication in the hospital - Analgesic medication at hospital discharge or after 6 weeks - Side effects (SAE and AE) - Success of rehabilitation measures

Countries

Germany

Contacts

Public ContactLeopold Eberhart

Klinik für Anästhesie & IntensivtherapiePhilipps-Universität Marburg

eberhart@uni-marburg.de++49 (0) 64215862945

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026